Bill Haney, Dragonfly

Ab­b­Vie lines up a new pre­clin­i­cal R&D al­liance with the deal­mak­ers at nat­ur­al killer play­er Drag­on­fly

Bill Haney is build­ing on his rep as one of the most pro­lif­ic deal­mak­ers in pre­clin­i­cal R&D, adding a new al­liance for Drag­on­fly Ther­a­peu­tics with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA